Möchten Sie immer auf dem neuesten Stand bleiben?

LEQEMBI IQLIK is a first-of-its-kind anti-amyloid treatment worldwide, offering at-home dosing for initiation and maintenance (approved in the U.S.) U.S. launch of LEQEMBI IQLIK as an initiation dose...

Record 2Q Total Revenue of $1.5 billion Adjusted EBITDAR Margin of 18% Operating Margin of 5% Liquidity(3) to LTM Revenue ratio at 22% MEXICO CITY, July 13, 2026 (GLOBE NEWSWIRE) -- Grupo...

Omnix Medical Launches EUR ~8M Horizon Europe PEPTAMR Infectious Disease Consortium to Advance Lead Program OMN6 Toward Clinical Phase III

TOKYO and CAMBRIDGE, Mass., July 12, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that new data presented at the Alzheimer’s Association International...

Dublin, July 10, 2026 (GLOBE NEWSWIRE) -- The "Advanced Therapeutics (Aging and Wellness) Market - A Global and Regional Analysis: Focus on Product Type, Application Type, Distribution Channel, and...

TORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- Today, Shoppers Drug Mart and Obesity Canada announced a new collaboration focused on advancing awareness of obesity as a chronic disease, reducing weight...

TORONTO, 08 juill. 2026 (GLOBE NEWSWIRE) -- Aujourd’hui, Shoppers Drug Mart et Obésité Canada ont annoncé une nouvelle collaboration visant à mieux faire connaître l’obésité comme maladie chronique,...

Boston, MA, July 07, 2026 (GLOBE NEWSWIRE) -- Monday marked the official launch of the 2026 six-week NextRise Summer program session, an initiative pioneered by the nonprofit Next Leadership...

Dr. Laws, former immunology leader at Sanofi, will oversee global development of Kymera’s KT-621 program KT-621 parallel Phase 2b trials advancing in AD and asthma, with data expected by year-end...

Denver, Colo., July 02, 2026 (GLOBE NEWSWIRE) -- The American Indian College Fund has appointed two tribal colleges presidents and two private sector professionals to the governing board of...